Biocancell Therapeutics Inc.

CIK 1451980 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Biocancell Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Aug 10, 2012EFFECT9999999995-12-002448
Aug 10, 2012EFFECT9999999995-12-002445
Aug 10, 2012EFFECT9999999995-12-002444
Aug 9, 2012S-8 POS0001178913-12-002221
Aug 9, 201215-12G0001178913-12-002230
Aug 9, 20128-K0001178913-12-002213
Aug 9, 2012POS AM0001178913-12-002228
Aug 9, 2012POS AM0001178913-12-002223
Aug 9, 2012POS AM0001178913-12-002225
Aug 7, 201240001178913-12-002171
Aug 7, 2012SC 13D/A0001178913-12-002173
Jul 31, 20128-K0001178913-12-002090
Jul 20, 20128-K0001451980-12-000065
Jul 20, 2012DEFA14A0001451980-12-000069
Jul 20, 2012DEFA14A0001451980-12-000067
Jun 7, 2012DEF 14A0001451980-12-000063
Jun 7, 2012DEF 14A0001451980-12-000061
May 25, 2012PRER14A0001451980-12-000049
May 10, 201210-Q0001178913-12-001404
May 9, 20128-K0001451980-12-000046
May 8, 20128-K0001451980-12-000044
Apr 25, 2012PRE 14A0001451980-12-000042
Apr 9, 20128-K0001451980-12-000040
Mar 30, 201210-K0001178913-12-000905
Mar 28, 201240001140361-12-017926